<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView%20%20&amp;noscript=1">
  • Menu
  • crown-logo-symbol-1-400x551

Find it Quickly

Get Started

Select the option that best describes what you are looking for

  • Services
  • Models
  • Scientific Information

Search Here For Services

Click Here to Start Over

Search Here For Models

Click Here to Start Over

Search Here For Scientific Information

Click Here to Start Over

In Vitro

Boost oncology drug discovery with XenoBase®, featuring the largest cell line selection and exclusive 3D organoid models. Benefit from OrganoidXplore™ and OmniScreen™ for rapid, in-depth analysis.

Learn More

In Vivo

Enhance drug development with our validated in vivo models, in vitro/ex vivo assays, and in silico modeling. Tailored solutions to optimize your candidates.

Learn More

Tissue

Experience ISO-certified biobanking quality. Access top biospecimens from a global clinical network, annotated by experts for precise research.

Learn More

Biomarkers and Bioanalysis

Leverage our global labs and 150+ scientists for fast, tailored project execution. Benefit from our expertise, cutting-edge tech, and validated workflows for reliable data outcomes.

Learn More

Data Science and Bioinformatics

Harness your data and discover biomarkers with our top bioinformatics expertise. Maximize data value and gain critical insights to accelerate drug discovery and elevate projects.

Learn More

KRAS

Accelerate innovative cancer treatments with our advanced models and precise drug screening for KRAS mutations, efficiently turning insights into clinical breakthroughs.

Learn More

EGFR

Advance translational pharmacology with our diverse pre-clinical models, robust assays, and data science-driven biomarker analysis, multi-omics, and spatial biology.

Learn More

Drug Resistance

Our suite integrates preclinical solutions, bioanalytical read-outs, and multi-omics to uncover drug resistance markers and expedite discovery with our unique four-step strategy.

Learn More

Patient Tissue

Enhance treatments with our human tumor and mouse models, including xenografts and organoids, for accurate cancer biology representation.

Learn More

Bioinformatics

Apply the most appropriate in silico framework to your pharmacology data or historical datasets to elevate your study design and analysis, and to improve your chances of clinical success.

Learn More

Biomarker Analysis

Integrate advanced statistics into your drug development projects to gain significant biological insight into your therapeutic candidate, with our expert team of bioinformaticians.

Learn More

CRISPR/Cas9

Accelerate your discoveries with our reliable CRISPR solutions. Our global CRISPR licenses cover an integrated drug discovery platform for in vitro and in vivo efficacy studies.

Learn More

Genomics

Rely on our experienced genomics services to deliver high quality, interpretable results using highly sensitive PCR-based, real-time PCR, and NGS technologies and advanced data analytics.

Learn More

In Vitro High Content Imaging

Gain more insights into tumor growth and disease progression by leveraging our 2D and 3D fluorescence optical imaging.

Learn More

Mass Spectrometry-based Proteomics

Next-generation ion mobility mass spectrometry (MS)-based proteomics services available globally to help meet your study needs.

Learn More

Ex Vivo Patient Tissue

Gain better insight into the phenotypic response of your therapeutic candidate in organoids and ex vivo patient tissue.

Learn More

Spatial Multi-Omics Analysis

Certified CRO services with NanoString GeoMx Digital Spatial Profiling.

Learn More

Biomarker Discovery

De-risk your drug development with early identification of candidate biomarkers and utilize our biomarker discovery services to optimize clinical trial design.

Learn More

DMPK Services

Rapidly evaluate your molecule’s pharmaceutical and safety properties with our in vivo drug metabolism and pharmacokinetic (DMPK) services to select the most robust drug formulations.

Learn More

Efficacy Testing

Explore how the novel HuGEMM™ and HuCELL™ platforms can assess the efficacy of your molecule and accelerate your immuno-oncology drug discovery programs.

Learn More

Laboratory Services

Employ cutting-edge multi-omics methods to obtain accurate and comprehensive data for optimal data-based decisions.

Learn More

Pharmacology & Bioanalytical Services

Leverage our suite of structural biology services including, recombinant protein expression and protein crystallography, and target validation services including RNAi.

Learn More

Screens

Find the most appropriate screen to accelerate your drug development: discover in vivo screens with MuScreen™ and in vitro cell line screening with OmniScreen™.

Learn More

Toxicology

Carry out safety pharmacology studies as standalone assessments or embedded within our overall toxicological profiling to assess cardiovascular, metabolic and renal/urinary systems.

Learn More

Our Company

Global CRO in California, USA offering preclinical and translational oncology platforms with high-quality in vivo, in vitro, and ex vivo models.

Learn More

Our Purpose

Learn more about the impact we make through our scientific talent, high-quality standards, and innovation.

Learn More

Our Responsibility

We build a sustainable future by supporting employee growth, fostering leadership, and exceeding customer needs. Our values focus on innovation, social responsibility, and community well-being.

Learn More

Meet Our Leadership Team

We build a sustainable future by fostering leadership, employee growth, and exceeding customer needs with innovation and social responsibility.

Learn More

Scientific Advisory Board

Our Scientific Advisory Board of experts shapes our strategy and ensures top scientific standards in research and development.

Learn More

News & Events

Stay updated with Crown Bioscience's latest news, achievements, and announcements. Check our schedule for upcoming events and plan your visit.

Learn More

Career Opportunities

Join us for a fast-paced career addressing life science needs with innovative technologies. Thrive in a respectful, growth-focused environment.

Learn More

Scientific Publications

Access our latest scientific research and peer-reviewed articles. Discover cutting-edge findings and insights driving innovation and excellence in bioscience.

Learn More

Resources

Discover valuable insights and curated materials to support your R&D efforts. Explore the latest trends, innovations, and expertly curated content in bioscience.

Learn More

Blogs

Explore our blogs for the latest insights, research breakthroughs, and industry trends. Stay educated with expert perspectives and in-depth articles driving innovation in bioscience.

Learn More

  • Platforms
  • Target Solutions
  • Technologies
  • Service Types
Background Image

Cell Line Authentication with Deep Sequencing

Patented Technology: Ensuring Precise and Reliable Biosample Authentication

Are your cell lines and biological models REALLY what you think they are? According to multiple studies, 1/5 to 1/3 of popular cell lines have been contaminated by intraspecies/interspecies cells, mycoplasma and/or viruses. The International Cell Line Authentication Committee (ICLAC) has documented a growing list of more than 530 misidentified cell lines (update in Jan 2023) having no known authentic stock.

Ensure confidence in your models and reproducibility of high quality data by using our deep sequencing-based cell line authentication service. The panel encompasses over 2000 SNPs and chromosome segments to accurately characterize mouse and human samples including cell lines, organoids, xenograft models, and patient tissues. We have also generated unique DNA fingerprints for the most commonly used oncology research models, covering over 1,200 human cancer and 90 mouse cell lines.

Conventional PCR-based STR assays target only 9 to 24 STR sites, depending on the vendors. The accuracy of the PCR-based STR assay can be low in cases of close genetic relationships such as the authentication of murine cell lines derived from specific strains of inbred animals that lack unique genetic markers and different tumor cell lineages from the same human donor. Further, biosamples with mutations in mismatch repair (MMR) genes are known to exhibit microsatellite instability and a hypermutator phenotype. Consequently, this can lead to genetic drift and/or outgrowth of contaminating cells and STR misclassification.

Cell Line Authentication with Deep Sequencing

Outperforms Conventional PCR-based STR/SNP Assays
  • Increased Accuracy
  • Increased Sensitivity
  • Higher Throughput
  • Extensive Information
  • Lower Cost Per Sample
  • Rapid Turnaround


With deep sequencing-based QC panel, you will achieve three-level sample authentication.



Client Testimonial

"We have used STR assays for cell line authentication in the past, but found that this technique lacks the sensitivity and ability to detect mouse cell contamination. Unlike other services, the cell line authentication service from Crown Bioscience provides a high-level of sensitivity and accuracy, and the ability to detect interspecies, and other, contamination so we can continue our ground-breaking research."

Professor Hongchun Liu,
Shanghai Institute of Materia Medica, Chinese Academy of Sciences


Cell Line (CLA) Authentication
Assay Comparison
CLA with Deep Sequencing CLA with PCR-based STR Assay
Technology Barcode deep sequencing


Multiplex PCR
& capillary electrophoresis

Readout Type Digital
(clean, near-zero quantification error)
Analog
(noisy, high quantification error)
Human Cell Authentication Yes Yes
Mouse Cell Authentication Yes Limited
MMR Deficient Cell lines identification Yes No
Contamination-Detecting Sensitivity High (1%) Low to medium (5-20%)
Accuracy High Low to medium
Throughput High Low
Contaminant Identification Yes No
Qualification of Contamination Ratio Yes No
Suitable for Large Biobanks Yes No
Interspecies Contamination Detection Yes Limited
Intraspecies Contamination Detection Yes Limited
Detecting Contamination w/o Reference Yes No
Estimating Mix Ratios for 3+ Cell Lines Yes (1% sensitivity) No

List of authenticatable human and mouse cell lines
NAR Genomics and Bioinformatics, Volume 2, Issue 3, September 2020, lqaa060 


Cell Line (CLA) Authentication
Assay Comparison
CLA with Deep Sequencing CLA with PCR-based STR Assay
Technology Barcode deep sequencing


Multiplex PCR
& capillary electrophoresis

Readout Type Digital
(clean, near-zero quantification error)
Analog
(noisy, high quantification error)
Human Cell Authentication Yes Yes
Mouse Cell Authentication Yes Limited
MMR Deficient Cell lines identification Yes No
Contamination-Detecting Sensitivity High (1%) Low to medium (5-20%)
Accuracy High Low to medium
Throughput High Low
Contaminant Identification Yes No
Qualification of Contamination Ratio Yes No
Suitable for Large Biobanks Yes No
Interspecies Contamination Detection Yes Limited
Intraspecies Contamination Detection Yes Limited
Detecting Contamination w/o Reference Yes No
Estimating Mix Ratios for 3+ Cell Lines Yes (1% sensitivity) No

Sample Requirements and Submission

 
Sample Type Amount Shipping Conditions
DNA Powder 100-500μg Room tempature (RT)
Liquid Wet ice
Cell Pellet At least 1 million cells

Dry ice

Fresh Tumor Tissue Snap Frozen At least 200mg or 1 million cells Dry ice
Formalin Fixed RT for delivery within 72hr
FFPE Tissue Unstained tissue sections (and H&E stained adjacent sections) RT

Download detailed sample preparation and collection guide

Frequently Asked Questions

 

What types of cells and models are better characterized with SNP compared to STR?

SNP is especially useful for cells:

  • With deficiencies in mismatch repair/microsatellite instability
  • Derived from closely related inbred strains
  • With chromosomal copy number aberrations


What is the turnaround time?

7-11 business days


How is gender determined?

Human gender is inferred via 3 SNPs on the Y chromosome. Please note that the Y chromosome is lost in some cancer genomes, therefore a predicted result of ‘female’ may not always be accurate.


Which human races can be determined?

Our panel can classify three reference populations, Han Chinese (CHB), Nigeria Yoruba (YRI), and Utah residents with Northern and Western European ancestry (CEU). The race can be predicted when >70% of total SNPs support one population.


What is considered a ‘match’?

Greater than 90% similarity ratio is considered a match.


What does the summary report look like?

Download example report here.

Request a quote